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Abstract
We report a case of adrenal insufficiency in patient with lung cancer. 
Although adrenal metastases are common in cancer patients, adrenal 
insufficiency is a rare occurrence. Diagnosis and treatment of adrenal 
insufficiency will improve the physical status and the quality of life 
in those patients.
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Introduction
Adrenal glands are a common site for metastases from solid 
tumors [1]. However, the occurrence of adrenal insufficiency 
is a very uncommon event [2], as 90% of the glands must be 
destroyed to cause adrenal insufficiency [3]. We present a case 
of a patient with a previously diagnosed non-small cell lung 
cancer (NSCLC) with known metastatic involvement of the 
adrenals, which evolved into adrenal failure.
Case Report
A 60-year-old male patient was admitted to the hospital with 
several-week history of weakness, adynamia and progressive 
loss of deambulation, having become bedridden at the last 
days before the hospitalization.
He was diagnosed 7 months ago with NSCLC in stage 
IV, with metastasis to the contralateral lung and both adrenal 
glands. He also had a history of primary hypertension.
On admission, he was dehydrated and his blood pressure 
(BP) was 77/45 mm Hg. The rest of the physical examination 
was irrelevant. Laboratory analyses revealed Hb 12.8 g/dL, 
sodium 117 mmol/L, potassium 6.2 mmol/L, creatinine 3.09 
mg/dL, blood urea nitrogen (BUN) 123 mg/dL, and C-reactive 
protein 5.16 mg/dL. Arterial blood gases sample (ambient air) 
showed pH 7.437, PCO2 19 mm Hg, PO2 98 mm Hg, HCO
3- 
12.6 mmol/L, and SO2- 98%.
He initiated normal saline infusion and cation exchange 
resin. Despite sorotherapy he remained hypotensive (BP 70/40 
mm Hg), but had mild improvement on laboratory evaluation 
as follows: sodium 127 mmol/L, potassium 5.3 mmol/L, cre-
atinine 1.85 mg/dL and BUN 48 mg/dL.
To assess the adrenal function, the next analyses were re-
alized: serum cortisol 3.48 μg/mL (normal 4.3 - 22.4), serum 
ACTH 181.8 pg/mL (4.7 - 48.8), serum aldosterone < 1 ng/
dL (1 - 16), plasma renin activity 31.76 μg/mL/h (0.37 - 3.84) 
and 24-h urinary cortisol 6.16 μg (28.5 - 213.7). Computed 
tomography (CT) scan of the abdomen showed a large nodular 
enlargement of both adrenal glands.
The diagnosis of metastatic primary adrenal insufficiency 
was established, and he initiated hormonal replacement therapy 
with hydrocortisone 5 mg tid and fludrocortisone 0.05 mg qd.
In the following days, the patient presented rapid clinical 
improvement, with normalization of his blood pressure. Labo-
ratory evaluation also showed normal electrolytes and renal 
function: Hb 9.06 g/dL, sodium 137 mmol/L, potassium 3.9 
mmol/L, creatinine 1.17 mg/dL, and BUN 21 mg/dL.
On discharge the patient had BP 118/64 mm Hg, and in 
the subsequent follow-ups he had recovered his autonomous 
deambulation.
Discussion
Metastases to the adrenal glands are a frequent finding in pa-
tients with advanced malignancies like lung, breast, gastric, 
and colorectal cancer, melanoma, and non-Hodgkin’s lympho-
ma. This occurs likely due to their rich sinusoidal supply [4]. 
For instance, large autopsy series have shown that the preva-
lence of adrenal metastases was as much as 42% in patients 
with lung cancer [5].
Most data on patients with adrenal insufficiency due to 
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adrenal metastases have been reported as clinical case reports 
[3, 4, 6-27]. In some of these cases adrenal insufficiency was 
the presenting feature of occult malignancy [4, 6-8, 10, 12, 
23-25, 27]. In a prospective study, one-third of patients with 
bilateral adrenal involvement by metastatic cancer had adrenal 
insufficiency based on cosyntropin test [28]. Seidenwurm et al 
found four cases of adrenal insufficiency in 21 patients (19%) 
with bilateral adrenal metastases or unilateral adrenal metas-
tases in patients with contralateral adrenalectomy [3]. On the 
other hand, in one retrospective study of 30 years with 464 
patients with adrenal metastatic disease from various tumors, 
only five of these patients developed adrenal insufficiency [2]. 
The differences in the frequency of adrenal insufficiency in 
these studies seem mainly to be due to the pre-selection of 
the patients and variable diagnostic criteria of adrenal insuf-
ficiency, ranging from solely clinical to stimulation tests, with 
some interpretations of test results questionable due to para-
neoplastic endogenous stimulation of the adrenal cortex and 
the consequent blunt response of cortisol to those tests [29].
Majority of patients with adrenal metastases have activa-
tion of the hypothalamic-pituitary-adrenal axis with strongly 
elevated cortisol levels [29, 30]. This is explained by the ac-
tivated hypothalamic-pituitary-adrenal axis due to increased 
physical and mental stress of tumor patients [30, 31] and in-
teraction between the tumor, the immune and the endocrine 
system [32]. This could explain why adrenal insufficiency is 
infrequent and develops only in patients with large bilateral 
metastases [29], with destruction of more than 90% of the 
functional cortex [33].
In addition to adrenal insufficiency that develops owing 
to replacement of both glands by metastases, other causes of 
adrenal insufficiency in cancer patients include hemorrhagic 
necrosis of adrenals in the context of metastatic infiltration, 
impaired adrenal synthesis in patients being treated with some 
anti-cancer drugs, metastases to the pituitary gland causing 
secondary adrenal insufficiency [27], and finally, even pa-
tients whose adrenal dysfunction is asymptomatic may have 
inadequate adrenal reserve if they become seriously ill, or can 
develop relative adrenal insufficiency after withdrawal of ster-
oids included in many treatment protocols. On the other hand, 
steroids included in many treatment protocols may mask the 
presence of preexistent adrenal insufficiency.
In patients with cancer, adrenal insufficiency may go un-
recognized because the symptoms, such as weakness, anorex-
ia, nausea, vomiting, dehydration and orthostatic hypotension, 
and laboratory abnormalities, such as hyponatremia, hyper-
kalemia, and pre-renal azotemia are nonspecific and may be 
attributed to the underlying progressive malignancy or to the 
cancer therapy. On the other hand, terminal stage cancer pa-
tients can have symptoms that overlap with symptoms of adre-
nal insufficiency. For instance, in a prospective study of seven 
patients with adrenal metastases, three of them had symptoms 
suggestive of adrenal insufficiency that was not confirmed by 
cosyntropin stimulation test [34].
Patients with bilateral adrenal metastases, particularly 
those with large bilateral metastases, should be evaluated for 
the presence of adrenal insufficiency and receive careful fol-
low-up, even if the baseline testing is normal. The treatment 
of the disease involves life-long administration of glucocorti-
coids and mineralocorticoids, which will improve the quality 
of life.
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